The most common transition in dentistry and medicine, and the one where the relationship makes everything harder to discuss.
THE SHORT ANSWER Start with an independent valuation before any number is discussed, because once a figure has been said out loud it anchors the whole negotiation and neither party can un-hear it. Expect the associate to need financing help, since lenders are cautious about goodwill and most associates cannot fund the full price at once. Decide early whether this is a single sale or a staged buy in over several years, as that choice changes the valuation, the tax treatment and the governance. Then put everything in a written agreement, including what happens if the associate wants out, if you want to retire earlier than planned, or if the two of you stop agreeing. The relationship is the reason this transition works and the reason it needs documenting properly
Selling to your associate is, on paper, the easiest transition available. They know the patients, the staff already trust them, there is no marketing process, and the practice continues without the disruption of a stranger arriving.
In practice it is the transition most likely to end in an awkward conversation, because the same relationship that makes it work makes it difficult to negotiate.
Neither party wants to seem opportunistic. The owner does not want to look like they are extracting maximum value from someone they trained. The associate does not want to look ungrateful by questioning the price. So both avoid the difficult parts, agree to something vague, and discover the problem eighteen months later.
Get the valuation before the conversation
This is the single most important sequencing decision, and most people get it backwards.
Once a number has been mentioned casually, it becomes the reference point for everything that follows. If you suggest a figure over coffee and later learn the practice is worth more, raising it looks like bad faith. If your associate names a number first and it is low, you spend the rest of the process arguing upward against their expectation.
An independent valuation removes that dynamic entirely. The number comes from a third party with no stake in the outcome, using a defensible methodology, and both of you are responding to the same document rather than to each other.
Why it matters more here than in an external sale
In an arm’s length sale, the market disciplines the price. Multiple buyers, competing offers, and a broker whose incentive is a higher number. None of that exists in an internal transition.
There is one buyer, one seller, a personal relationship, and no market test. The valuation is the only objective input in the room, which is why skipping it tends to produce either a price the owner resents later or one the associate cannot service.
| THE CONVERSATION THAT SAVES THE DEAL Tell your associate you are commissioning an independent valuation before discussing price, and that you will both work from it. That single sentence takes the negotiation out of your relationship and puts it into a document. Associates are almost always relieved, because they were dreading the conversation as much as you were. |
The financing problem
Most associate purchases stall here rather than on price.
An associate a few years out of school typically carries student debt, limited savings and a short credit history as a business borrower. Lenders are cautious about practice goodwill because it is not an asset they can easily recover, so financing rarely covers the full purchase price.
That leaves a gap, and how you handle it is the real negotiation.
| Structure | How it works | Consider |
| Full payment at closing | Associate finances the entire price | Cleanest for you, often not achievable |
| Vendor take back financing | You finance part of the price over time | Common and workable, but you carry risk |
| Staged buy in | Associate buys a percentage at a time | Spreads cost, requires governance rules |
| Earn out | Part of price tied to future performance | Aligns interests, complicates the exit |
| Deferred payment | Fixed payments after closing | Simpler than an earn out, still carries risk |
Vendor financing, honestly
Financing part of the sale yourself is extremely common in internal transitions, and it is genuinely the thing that makes many of them possible. It also means you have not fully exited. You are now a creditor of a business you no longer control, run by someone whose performance determines whether you get paid.
If you go this route, treat it as a loan rather than a handshake. Interest rate, payment schedule, security, and what happens on default all need documenting. An arrangement that feels uncomfortable to write down is one that will be much more uncomfortable to enforce.
Single sale or staged buy in?
The other structural decision, and it has consequences well beyond the price.
The single sale
You sell, you leave, the transition period is defined and finite. Cleanest outcome, hardest to finance, and it works best when the associate has been in place long enough to hold the patient base on their own.
The staged buy in
The associate purchases a minority stake, then increases it over several years until they own the practice outright. Easier to finance, keeps you involved during the handover, and lets the associate grow into ownership rather than arriving in it.
The catch is that you are now partners, and partners need rules. What happens when you disagree about a major purchase? Who decides on hiring? What if one of you wants to exit early? What if the associate’s performance drops, or yours does as you wind down?
Staged buy ins fail on governance far more often than on price. Every one of those questions should be answered in writing before the first tranche changes hands, not when the disagreement arrives.
| Get the number before you have the conversation. IS Advisory provides independent valuations for dental, medical, pharmacy and veterinary practices across Canada. An objective number both parties can work from, so the negotiation does not have to happen inside the relationship. Book a confidential consultation at isadvisory.ca |
What tends to go wrong
1. A number is mentioned casually before any valuation exists, and it anchors everything afterwards.
2. The owner assumes loyalty means the associate will accept the price. The associate assumes loyalty means the owner will discount it. Neither says so.
3. Financing is left until after the price is agreed, and the deal stalls once the lender declines.
4. A staged buy in is documented on price but not on decision making, and the first real disagreement has no process to resolve it.
5. The transition period is undefined, so the owner stays longer than the associate wants or leaves sooner than the patients can absorb.
6. Nobody addresses what happens if it does not work out, which is the clause everyone regrets omitting.
What to put in writing
Whatever the structure, these belong in the agreement rather than in an understanding.
- The price, and how it was determined. And the methodology behind it, so it is defensible later if anyone questions it.
- The payment terms in full. Amount, interest, schedule, security, and consequences of missed payments.
- The transition period. How long you stay, in what capacity, doing what, and who decides when it ends.
- Restrictive covenants. Whether you can practise nearby afterwards, for how long, and within what radius.
- Decision making authority. For a staged buy in, who decides what at each ownership level.
- Exit provisions. What happens if either party wants out, becomes ill, or dies before completion.
- Dispute resolution. Arbitration, mediation, or a defined process. Anything other than hoping it will not be needed.
Structure and tax treatment interact with all of this, and the two are best worked on together rather than in sequence. Whether the transaction is structured as an asset sale or a share sale affects both parties differently, and some tax positioning requires lead time measured in years rather than months.